Evidence map›Paper›PMID 41612851›Full record

ArticleEndocrinology2026

Selenoprotein P deletion ameliorates metabolic stress-associated anxiety-like behavior in male mice.

Guzel Gafiyatullina, Anna Shabalova, Hisanori Goto, Hein Ko Oo, Kengo Saito, Ryota Tanida, Qifang Li, Kyoko Kamoshita, Cynthia M Galicia-Medina, Yujiro Nakano and 11 more

Abstract read
In one paragraph

Article in Endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Guzel GafiyatullinaDepartment of Endocrinology and Metabolism, Kanazawa University Graduate School of Advanced Preventive Medical Sciences, Ishikawa 920-8640, Japan.ORCID 0009-0008-7777-449X
Anna ShabalovaDivision of Basic Science and Translational Research, Kanazawa University, Kanazawa 920-8640, Japan.ORCID 0000-0001-6658-0202
Hisanori GotoDepartment of Endocrinology and Metabolism, Kanazawa University Graduate School of Advanced Preventive Medical Sciences, Ishikawa 920-8640, Japan.ORCID 0009-0008-4723-6156
Hein Ko OoDepartment of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan.
Kengo SaitoDepartment of Medical Neuroscience, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan.ORCID 0000-0002-4520-3675
Ryota TanidaDepartment of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan.ORCID 0000-0003-2609-6613
Qifang LiDepartment of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan.
Kyoko KamoshitaDepartment of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan.
Cynthia M Galicia-MedinaDepartment of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan.ORCID 0009-0000-8417-9906
Yujiro NakanoDepartment of Endocrinology and Metabolism, Kanazawa University Graduate School of Advanced Preventive Medical Sciences, Ishikawa 920-8640, Japan.ORCID 0000-0003-1620-7164
Yumie TakeshitaDepartment of Endocrinology and Metabolism, Kanazawa University Graduate School of Advanced Preventive Medical Sciences, Ishikawa 920-8640, Japan.ORCID 0000-0002-0475-1931
Kiyo-Aki IshiiDepartment of Endocrinology and Metabolism, Kanazawa University Graduate School of Advanced Preventive Medical Sciences, Ishikawa 920-8640, Japan.ORCID 0000-0001-9846-5575
Hiroaki TakayamaDepartment of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan.ORCID 0000-0003-4792-3868
Chiharu TsujiDivision of Basic Science and Translational Research, Kanazawa University, Kanazawa 920-8640, Japan.ORCID 0000-0002-4843-7848
Haruhiro HigashidaDivision of Basic Science and Translational Research, Kanazawa University, Kanazawa 920-8640, Japan.ORCID 0000-0002-1779-0606
Yohei ShinmyoDepartment of Medical Neuroscience, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan.ORCID 0000-0002-1000-4756
Hiroshi KawasakiDepartment of Medical Neuroscience, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan.ORCID 0000-0002-2514-1497
Hiromasa TsujiguchiDepartment of Public Health, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Ishikawa 920-8640, Japan.
Akinori HaraDepartment of Public Health, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Ishikawa 920-8640, Japan.ORCID 0000-0002-0399-1474
Hiroyuki NakamuraDepartment of Public Health, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Ishikawa 920-8640, Japan.ORCID 0000-0002-4461-2098
Toshinari TakamuraDepartment of Endocrinology and Metabolism, Kanazawa University Graduate School of Advanced Preventive Medical Sciences, Ishikawa 920-8640, Japan.ORCID 0000-0002-4393-3244

Funding

Japan Society for the Promotion of Science 21K19503MEXT Scholarship ProgramTakeda Science Foundation
6 · The paper itself

Abstract

contextDiabetes-associated metabolic stress and anxiety reciprocally influence one another's onset and course. We previously linked excessive selenoprotein P (SeP, encoded by SELENOP in humans) to pathological conditions frequently observed in individuals with diabetes.

objectiveThe present study aimed to clarify the role of SeP in the metabolic stress-induced anxiety.

methodsWe visualized Selenop expression in the mouse brain section via RNAscope in situ hybridization and used RT-qPCR to evaluate gene expression in brain regions. We created brain-specific Selenop knockout (bSelenop-/-) mice by mating Selenop-flox and Nestin-Cre mice and conducted behavior tests for anxiety-like behavior and spatial memory under both a standard (STD) and high-fat, high-sucrose diet (HFHSD) conditions. In a cross-sectional general population cohort study, we examined differences in serum selenoprotein P concentrations between individuals with and without anxiety symptoms.

resultsRNAscope in situ hybridization identified glial and endothelial cells as the sources of SeP synthesis in the brain. Selenop was expressed at the same level in the brains of mice fed with an STD and HFHSD. bSelenop-/- mice did not exhibit altered body weight or glucose tolerance associated with HFHSD feeding. High-fat, high-sucrose diet aggravated the anxiety-like behavior in the control mice, whereas Selenop deletion in the brain ameliorated the anxiety-like behavior without affecting spatial memory. Epidemiological data revealed that serum selenoprotein P was significantly higher in subjects with anxiety symptoms. CONCLUSION/

interpretationThese findings suggest that excess SeP production may be a common trait linking metabolic stress with anxiety.

Indexed as

AnxietySelenoprotein PStress, PhysiologicalAnimalsBehavior, AnimalBrainDiet, High-FatMaleMiceMice, Inbred C57BLMice, KnockoutSelenoprotein Panxietydiabetes type 2diet effectsHFHSDmetabolic stressselenoprotein P

Identifiers

PMID41612851
PMCPMC12856044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.